Change in Insulin Dose and HbA1c by Geographical Region-Results from the Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) Study

被引：0
|
作者：
Mauricio, Didac
Meneghini, Luigi
Orsi, Emanuela
Klimontov, Vadim
Westerbacka, Jukka
Melas-Melt, Lydie
Pilorget, Valerie
Perfetti, Riccardo
Khunti, Kamlesh
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1037-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Superior reduction of HbA1c in a double-blind, randomised study of basal insulin peglispro (BIL) vs insulin glargine (GL) in patients with type 1 diabetes: IMAGINE 3
    Lunt, H.
    Bergenstal, R. M.
    Franek, E.
    Travert, F.
    Mou, J.
    Hartman, M. L.
    Rosilio, M.
    Bastyr, E. J., III
    DIABETOLOGIA, 2015, 58 : S468 - S468
  • [32] A basal-bolus regimen of insulin glargine and insulin glulisine results in a lower rate of hypoglycaemia relative to endpoint HbA1c versus twice-daily premixed insulin in type 2 diabetes patients
    Fritsche, A.
    Larbig, M.
    Haering, H. -U.
    DIABETOLOGIA, 2010, 53
  • [33] Superior HbA1c reduction with basal insulin peglispro (BIL) vs insulin glargine (GL) and preprandial insulin lispro in a double-blind study in type 2 diabetes patients: IMAGINE 4
    Chang, A. M.
    Blevins, T.
    Pieber, T. R.
    Vega, G. Colon
    Zhang, S.
    Bastyr, E. J., III
    DIABETOLOGIA, 2015, 58 : S470 - S471
  • [34] Lower HbA1c after 1 year, in children with type 1 diabetes treated with insulin glargine vs. NPH insulin from diagnosis: a retrospective study
    Salemyr, Jenny
    Bang, Peter
    Ortqvist, Eva
    PEDIATRIC DIABETES, 2011, 12 (05) : 501 - 505
  • [35] Combining HbA1c and insulin resistance to assess the risk of gestational diabetes mellitus: A prospective cohort study
    Yin, Binbin
    Ding, Lijing
    Chen, Zhuopeng
    Chen, Yan
    Zhu, Bo
    Zhu, Yuning
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 199 : 1 - 8
  • [36] Effect on HbA1c of switching to insulin degludec from another basal insulin: the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit
    Lumb, A. N.
    Rea, R. D.
    Abraham, R.
    McDonald, P.
    Bain, S. C.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2017, 34 : 88 - 89
  • [37] Langfristiger HbA1c-Verlauf in insulinbehandelten Typ-2-Diabetes-Patienten aus ArztpraxenLongitudinal change in HbA1c in patients with type 2 diabetes: comparison of short-acting, biphasic and basal insulin
    B. Rose
    Der Diabetologe, 2009, 5 : 360 - 361
  • [38] Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study
    Goldenberg, Ronald M.
    Aroda, Vanita R.
    Billings, Liana K.
    Donatsky, Anders Meller
    Frederiksen, Marie
    Klonoff, David C.
    Kalyanam, Balamurali
    Bergenstal, Richard M.
    DIABETES THERAPY, 2023, 14 (05) : 915 - 924
  • [39] Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study
    Ronald M. Goldenberg
    Vanita R. Aroda
    Liana K. Billings
    Anders Meller Donatsky
    Marie Frederiksen
    David C. Klonoff
    Balamurali Kalyanam
    Richard M. Bergenstal
    Diabetes Therapy, 2023, 14 : 915 - 924
  • [40] Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia
    Ospina, Naykky Singh
    Montori, Victor M.
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (02)
12345